Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

Thermo Fisher to offer clients Horizon's X-MAN cell line tech

24-Apr-2015 - Thermo Fisher has added X-MAN cell line services to its biopharma R&D offerings through a supply agreement with Horizon Discovery Group.

Merck 'bio-inks' deal to use Organovo's 3D printed liver for preclinical studies

23-Apr-2015 - Merck & Co. has struck a deal with Organovo to use a 3D printed human liver system for toxicology testing as a supplement to in vitro and preclinical animal testing....

HLS and Harlan create hairless mouse model

20-Apr-2015 - Huntingdon Life Sciences and Harlan Laboratories have launched a highly immunocompromised hairless mouse model for oncology and immunology research.

Russia sees slight dip in clinical trial approvals in Q1 2015

15-Apr-2015 - The Ministry of Health of the Russian Federation approved 151 total clinical studies in Q1 of 2015, which is 11% less than the same quarter last year, though by comparison,...

AstraZeneca inks two research partnerships with PatientsLikeMe, Lead Discovery Center

14-Apr-2015 - With an eye on early-phase research, AstraZeneca has signed two deals – a five-year agreement to gain access to PatientsLikeMe’s network, and a three-year alliance with the Lead Discovery Center.

Eisai inks R&D Genomics data deal; cuts 25% US jobs

13-Apr-2015 - Eisai has inked a deal with a genome analytics firm to aid drug discovery days after announcing it would be cutting 25% of its in-house US workforce.

Takeda looks to BioXcel to help repurpose old assets for new rare disease indications

09-Apr-2015 - Takeda’s development center in the US has agreed to partner with BioXcel, a cloud-based big data solution provider, to repurpose old medicines to help treat rare diseases. 

Preclinical consolidation: MSI firm Protea buys CRO vivoPharm

08-Apr-2015 - Molecular imaging company Protea Biosciences has acquired CRO vivoPharm in the latest instance of consolidation in the preclinical sector.

Sanofi, Schrödinger forge up to $120m drug discovery deal

03-Apr-2015 - Computational drug designer Schrödinger has entered into a five-year early drug discovery collaboration with Sanofi in which Schrödinger will provide target analysis and validation to lead identification and lead optimization...

Venn seeks drug industry customers for skin substitute used to test cosmetics

03-Apr-2015 - London-listed CRO Venn Life Sciences hopes partnering with academics will help generate drug industry interest in its recently expanded skin model tech business.

UK politician pledge would ban 89% of animal research, say scientists

31-Mar-2015 - British MPs have signed an anti-animal cruelty pledge which scientists warn would “cripple” disease research and outlaw 89% of preclinical animal research.

Drug safety, crop protection and animal testing alternatives mulled at SOT

30-Mar-2015 - Employee safety is a focus for drugmakers and a growing market for the preclinical testing services sector according to Huntingdon Life Sciences.

PETA joins preclinical CROs at SOT to promote animal testing alternatives

27-Mar-2015 - Testing the toxicity of drug candidates in animals is archaic and unreliable according to PETA, which joined preclinical CROs at SOT to put forward alternatives.

Nottingham’s CRO forest thriving: UK Contractors tout new collaboration model

25-Mar-2015 - Some drug industry sponsors shy away from “jack of all trades” contractors according to a recently formed UK CRO network which says smaller firms with specific expertise can win market...

Ebola, eCigarettes and microbiomes: Hot topics at Society of Toxicology annual meeting

24-Mar-2015 - Ebola, electronic cigarettes and microbiomes are opportunities for the preclinical research sector according to delegates at a US industry conference this week.

Harvard-MIT institute partners with Google-backed Calico to study aging-related diseases

18-Mar-2015 - The Broad Institute of MIT and Harvard has entered into a partnership with Calico to study the biology and genetics of aging as part of early-stage drug discovery efforts. 

Animal rights protests have had little impact on preclinical services sector say CROs

17-Mar-2015 - Animal rights protests have not hurt the non-clinical services sector according to leading CROs which say vital drug development work has continued.

Altasciences allies with nonclinical service org to offer more complete early development tools

10-Mar-2015 - Early phase clinical research service provider Altasciences is forming a strategic alliance with ITR Laboratories, a nonclinical services organization, to help more mutual clients customize their drug development programs from...

Exclusive interview

Preclinical prices improving says Huntingdon CEO; firm is mulling US capacity expansion

05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told the preclinical CRO may add scale to US...

CRL’s bottom line continues to be driven by biotech growth, CEO says

05-Mar-2015 - For the second straight year Charles River Laboratories has seen more of its revenue derived from biotech companies than Big Pharma, CEO James Foster told investors at two conferences on...

Huntingdon to be renamed to mark Harlan integration

24-Feb-2015 - Huntingdon Life Sciences has announced it will change its name this year, but has not disclosed what its new moniker will be. So would welcome readers’ suggestions.

Crown Bioscience nabs PDX models, service ops of Molecular Response

17-Feb-2015 - Preclinical CRO Crown is acquiring all of Molecular Response’s existing PDX (patient-derived xenograft) models as well as 8,000 viable human tumors for model development.

Charles River ‘hot in pursuit’ of discovery company acquisitions

16-Feb-2015 - Charles River Laboratories is nearing the acquisition of an early-stage drug discovery company, CEO James Foster told attendees at the Leerink Swann Global Healthcare Conference last week.

Charles River moves forward with plans to re-open Massachusetts preclinical site

11-Feb-2015 - CRO Charles River Laboratories is further exploring the idea of re-opening a preclinical site in Shrewsbury, MA, though it will be more than a year before the site is ready.

Horizon partners on R&D with Rockefeller Uni, Sloan-Kettering, Cornell

02-Feb-2015 - Contract research organization (CRO) Horizon has been selected as a “core facility” for supplying biopharma research tools to academic group the Tri-Institutional Therapeutics Discovery Institute.

Key Industry Events